603658 Stock Overview
Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Autobio Diagnostics Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥53.20 |
| 52 Week High | CN¥66.36 |
| 52 Week Low | CN¥41.01 |
| Beta | -0.098 |
| 1 Month Change | -12.74% |
| 3 Month Change | 7.09% |
| 1 Year Change | -8.83% |
| 3 Year Change | -44.27% |
| 5 Year Change | 12.66% |
| Change since IPO | 69.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603658 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -2.5% | -2.4% | -0.2% |
| 1Y | -8.8% | -23.1% | -17.8% |
Return vs Industry: 603658 exceeded the CN Medical Equipment industry which returned -23.1% over the past year.
Return vs Market: 603658 exceeded the CN Market which returned -17.8% over the past year.
Price Volatility
| 603658 volatility | |
|---|---|
| 603658 Average Weekly Movement | 6.1% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 603658 has not had significant price volatility in the past 3 months.
Volatility Over Time: 603658's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 5,510 | Zeng Li Yang | www.autobio.com.cn |
Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products. It develops immunoassay, biochemistry, and microbiology products, as well as reagents; and instruments, as well as medical laboratory solutions. The company’s immunoassay products AutoLumo A1860 that provides user experience for small and medium size labs; an automated chemiluminescence immunoassay analyzer; AutoLumo A2000 Plus, an automatic chemiluminescence immunoassay analyzer; AutoLumo A1000, an automated chemiluminescence immunoassay analyzer; and LUmo microplate luminometers, PHOmo microplate readers, and iWO and iWO-960 microplate washers.
Autobio Diagnostics Co., Ltd. Fundamentals Summary
| 603658 fundamental statistics | |
|---|---|
| Market cap | CN¥30.91b |
| Earnings (TTM) | CN¥1.30b |
| Revenue (TTM) | CN¥4.50b |
23.8x
P/E Ratio6.9x
P/S RatioIs 603658 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603658 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.50b |
| Cost of Revenue | CN¥1.54b |
| Gross Profit | CN¥2.96b |
| Other Expenses | CN¥1.66b |
| Earnings | CN¥1.30b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Apr 19, 2024
| Earnings per share (EPS) | 2.24 |
| Gross Margin | 65.86% |
| Net Profit Margin | 28.90% |
| Debt/Equity Ratio | 5.5% |
How did 603658 perform over the long term?
See historical performance and comparison